SNTI Stock Analysis: Buy, Sell, or Hold?

SNTI - Senti Biosciences, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.99
0.03 (3.09%) ▲
5d: +5.13%
30d: -4.82%
90d: +0.87%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 06, 2026

Get Alerted When SNTI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: SNTI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SNTI is currently trading at $0.99, which is considered fair relative to its 30-day fair value range of $0.94 to $1.01.

Technical Outlook: Technically, SNTI is showing sideways momentum. Immediate support is located at $0.91, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 3.1% recently.

Market Sentiment: SNTI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.25 (+1071.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.94 - $1.01
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 92.1%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.1%)
  • BULLISH: Trading 1071.6% below Wall St target ($11.25)

Trading Range Analysis

30-Day Trading Range $0.94 - $1.01
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.91
Resistance Level $1.05
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.01
Wall Street Target $11.25 (+1071.6%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 15, 2026 11:09 AM ET
Data refreshes hourly during market hours. Next update: 12:09 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SNTI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 63 BUY
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 52 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$119 60 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$256 59 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 49 HOLD

More Analysis for SNTI

SNTI Technical Chart SNTI Price Prediction SNTI Earnings Date SNTI Investment Advisor SNTI Fair Price Analyzer SNTI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals